Recall Z-2481-2021— Leica Microsystems, Inc.
Class II · Terminated
Class II FDA medical device recall by Leica Microsystems, Inc., initiated 2021-07-30, terminated 2023-06-22. FDA's recall record names no specific 510(k) clearance for this event. Product: BOND Ready-To-Use Primary Antibody CDX2 (EP25), REF PA0375. Reason: Product may not perform as specified in IFU..
- Recalling firm
- Leica Microsystems, Inc.
- Classification
- Class II
- Status
- Terminated
- Initiated
- 2021-07-30
- Terminated
- 2023-06-22
- Firm location
- Buffalo Grove, IL, United States
Product description
BOND Ready-To-Use Primary Antibody CDX2 (EP25), REF PA0375
Reason for recall
Product may not perform as specified in IFU.
Data sourced from openFDA. This site is unofficial and independent of the FDA.